In summary, our study illustrated a clearer genomic landscape in Chinese lung adenocarcinoma patients of PD-L1 expression and relevant immune signatures from public database for interpreting the potential molecular mechanisms for clinical immunotherapy in NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.